ORPEA (ORP.PA)
FR0000184798 - Common Stock
2.13 0 (-0.19%)
Fundamental Rating
Taking everything into account, ORP scores 1 out of 10 in our fundamental rating. ORP was compared to 8 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ORP have multiple concerns. ORP is quite expensive at the moment. It does show a decent growth rate.
Note: ORP has only limited data available, so a full analysis was not possible, which makes the total rating unfair.
Profitability
Profitability Rating
VS Industry
Valuation
Valuation Rating
ORP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORP. No positive earnings are expected for the next year.
VS Industry
Growth
Growth Rating
The Earnings Per Share is expected to grow by 45.08% on average over the next 5 years. This is a very strong growth
Looking at the last year, ORP shows a small growth in Revenue. The Revenue has grown by 8.89% in the last year.
The Revenue has been growing slightly by 8.33% on average over the past 5 years.
The Revenue is expected to grow by 9.20% on average over the next 5 years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
ORP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6278.86%.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -6278.86% | 87.23% | 45.08% | N/A | N/A |
| Revenue | 8.33% | 7.76% | 8.89% | 9.66% | 8.19% | 9.2% | N/A |
Health
Health Rating
A Current Ratio of 0.19 indicates that ORP may have some problems paying its short term obligations.
Compared to an average industry Current Ratio of 1.32, ORP is worse placed to pay its short term obligations than its industry peers. 100% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.19 indicates that ORP may have some problems paying its short term obligations.
When comparing the Quick Ratio of ORP to the average industry Current Ratio of 0.96, ORP is less able to pay its short term obligations than its industry peers. 100% of its industry peers have a better Quick Ratio.
VS Industry
Quick Ratio (0.19) VS Industry: 0% outperformed.
0.19
2.44
Current Ratio (0.19) VS Industry: 0% outperformed.
0.19
3.05
Dividend
Dividend Rating
ORP does not give a dividend.
ORPEA
EPA:ORP (5/30/2023, 5:29:00 PM)
2.13
0 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap137.66M
Analysts41.82
Price Target5.05 (137.09%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)0%
PT rev (3m)-3.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-153.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | 0.55 | ||
| P/OCF | 0.34 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-62.31
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)3.88
FCFY182.35%
OCF(TTM)6.34
OCFY297.64%
SpS72.43
BVpS-23.24
TBVpS-68.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM | N/A | ||
| GM | N/A |
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 53.31 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC3.35%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-6278.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-10736.81%
EPS Next Y87.23%
EPS Next 2Y45.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y8.89%
Revenue growth 3Y7.76%
Revenue growth 5Y8.33%
Revenue growth Q2Q110%
Revenue Next Year9.66%
Revenue Next 2Y8.19%
Revenue Next 3Y9.2%
Revenue Next 5YN/A
EBIT growth 1Y-117.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5999.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.55%
FCF growth 3Y41.64%
FCF growth 5YN/A
OCF growth 1Y-45.64%
OCF growth 3Y-20.21%
OCF growth 5Y0.59%
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the EuroNext
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the EuroNext
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the EuroNext
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the EuroNext